Parabilis Medicines, Inc. (PBLS)
CIK 1657677 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Parabilis Medicines, Inc..
Recent SEC filings
| Filed | Form | Accession number |
|---|---|---|
| Sep 2, 2026 | 8-K | 0001193125-26-380171 |
| Aug 25, 2026 | 8-K | 0001193125-26-365132 |
| Aug 25, 2026 | 4 | 0001193125-26-365484 |
| Aug 25, 2026 | 3 | 0001193125-26-365459 |
| Aug 14, 2026 | SCHEDULE 13G | 0001193125-26-352189 |
| Aug 13, 2026 | 10-Q | 0001193125-26-349168 |
| Aug 13, 2026 | 8-K | 0001193125-26-347869 |
| Aug 6, 2026 | SCHEDULE 13G | 0000315066-26-002123 |
| Jul 22, 2026 | 4 | 0001231919-26-000779 |
| Jun 29, 2026 | 3 | 0001213900-26-072925 |
| Jun 29, 2026 | 4 | 0001213900-26-072928 |
| Jun 18, 2026 | SCHEDULE 13D | 0001346824-26-000178 |
| Jun 16, 2026 | 4 | 0001193125-26-273013 |
| Jun 15, 2026 | 4 | 0001193125-26-271324 |
| Jun 15, 2026 | 4 | 0001193125-26-271344 |
| Jun 15, 2026 | 4 | 0001193125-26-271300 |
| Jun 15, 2026 | 4 | 0001231919-26-000638 |
| Jun 11, 2026 | 4 | 0001193125-26-267802 |
| Jun 11, 2026 | 4 | 0001193805-26-000798 |
| Jun 11, 2026 | 4 | 0001193125-26-267766 |
| Jun 11, 2026 | 8-K | 0001193125-26-267550 |
| Jun 11, 2026 | 4 | 0001231919-26-000623 |
| Jun 11, 2026 | 4 | 0001193125-26-267769 |
| Jun 11, 2026 | 4 | 0001193125-26-267747 |
| Jun 11, 2026 | 4 | 0001193125-26-267797 |